Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728123) titled 'Screen2Prevent (S2P)' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).

Primary Sponsor: Westat

Condition: HIV Infections

Intervention: Other: HIV screening strategies

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: June 16, 2026

Target Sample Size: 84000

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07728123

Disclaimer: Curated by HT Syndication....